Publicaciones en las que colabora con Luis Alou Cervera (36)

2016

  1. Compendio de microbiología

    Elsevier

2014

  1. A new biocompatible and antibacterial phosphate free glass-ceramic for medical applications

    Scientific Reports, Vol. 4

2013

  1. Influence of the MBC/MIC ratio on the antibacterial activity of vancomycin versus linezolid against methicillin-resistant Staphylococcus aureus isolates in a pharmacodynamic model simulating serum and soft tissue interstitial fluid concentrations reported in diabetic patients

    Journal of Antimicrobial Chemotherapy, Vol. 68, Núm. 10, pp. 2291-2295

  2. Protection of Enterococcus faecalis in mixed cultures with carbapenemase-producing Escherichia coli and Bacteroide fragilis: effect of the bacterial load.

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26, Núm. 3, pp. 220-225

2012

  1. Cefditoren and Ceftriaxone Enhance Complement-Mediated Immunity in the Presence of Specific Antibodies against Antibiotic-Resistant Pneumococcal Strains

    PLoS ONE, Vol. 7, Núm. 9

  2. Efecto de la unión a proteínas en la actividad de voriconazol solo o combinado con anidulafungina frente aspergillus spp. Mediante curves de letalidad

    Revista Espanola de Quimioterapia, Vol. 25, Núm. 1, pp. 47-55

  3. Inhibitory effect on in vitro streptococcus oralis biofilm of a soda-lime glass containing silver nanoparticles coating on Titanium Alloy

    PLoS ONE, Vol. 7, Núm. 8

2011

  1. Activity of simulated serum concentrations of daptomycin versus vancomycin during the first 24 h of treatment in the presence of physiological albumin concentrations against vancomycin-susceptible, -tolerant or -intermediate- resistant Staphylococcus aureus

    International Journal of Antimicrobial Agents, Vol. 37, Núm. 4, pp. 332-338

  2. Efficacy of simulated cefditoren versus amoxicillin-clavulanate free concentrations in countering intrastrain ftsI gene diffusion in Haemophilus influenzae

    Antimicrobial Agents and Chemotherapy, Vol. 55, Núm. 6, pp. 2788-2794

2010

  1. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2 μg/mL

    International Journal of Antimicrobial Agents, Vol. 35, Núm. 2, pp. 131-137

  2. Cefditoren versus ceftazidime in inducersubstrate combinations for the evaluation of AmpC production in a disc approximation test

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 2, pp. 72-75

  3. Enhanced in vivo activity of cefditoren in preimmunized mice against penicillin-resistant S. pneumoniae (Serotypes 6B, 19F and 23F) in a sepsis model

    PLoS ONE, Vol. 5, Núm. 8

  4. Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria

    International Journal of Antimicrobial Agents, Vol. 36, Núm. 2, pp. 137-144

  5. In vitro killing activity of crevicular concentrations of tinidazole plus common oral antibiotics against high-density mixed inocula of periodontal pathogens in strict anaerobic conditions

    Journal of Periodontology, Vol. 81, Núm. 1, pp. 131-138

2009

  1. Genotypic versus phenotypic characterization, with respect to β-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to β-lactam resistance markers

    Antimicrobial Agents and Chemotherapy, Vol. 53, Núm. 1, pp. 267-270

  2. In vitro effect of physiological concentrations of human albumin on the antibacterial activity of tigecycline

    Journal of Antimicrobial Chemotherapy, Vol. 64, Núm. 6

  3. Influence of different resistance traits on the competitive growth of Haemophilus influenzae in antibiotic-free medium and selection of resistant populations by different β-lactams: An in vitro pharmacodynamic approach

    Journal of Antimicrobial Chemotherapy, Vol. 63, Núm. 6, pp. 1215-1222

2008

  1. Breakthrough in penicillin resistance? Streptococcus pneumoniae isolates with penicillin/cefotaxime MICs of 16 mg/L and their genotypic and geographical relatedness

    Journal of Antimicrobial Chemotherapy, Vol. 62, Núm. 6, pp. 1234-1240

  2. Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 8, pp. 679-683

  3. Decrease in bacterial load versus resistance selection of pneumococcal subpopulations by β-lactam physiological concentrations over time: An in vitro pharmacodynamic simulation

    Microbial Drug Resistance, Vol. 14, Núm. 1, pp. 13-21